Search

everythinglearnresearchcommunity

for

Search:↓

Hematopoietic stem cell transplantation does not significantly affect COVID-19 severity in children with immune disorders.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Eyebrow follicles are best for accurate genetic testing after stem cell transplants.

Patients often experience long-lasting changes to their hair after stem cell transplants.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Rehabilitation improved patients' mobility but did not reduce 30-day hospital readmission rates after stem cell transplants.

The study found that the quality of cord blood units remains consistent before freezing and after thawing, indicating that attached tube segments reliably represent the graft's properties.

Stem-cell therapy shows promise for skin conditions but needs more research.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

A new one-step test can quickly identify skin cancer during surgery.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Two brothers from Bangladesh were diagnosed with X-linked adrenoleukodystrophy, showing neurological and adrenal symptoms.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

A woman had temporary hair loss due to stress from a spinal cord injury.

The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.

PRP is a safe natural treatment that improves skin by reducing wrinkles and enhancing texture for up to 4 months.

PRP treatment showed no hair regrowth improvement after the first application in patients with alopecia.